Gov. Evers Appoints Brenda Yaskal to Serve as Columbia County District Attorney
"Brenda Yaskal is a seasoned criminal prosecutor who will bring more than a decade of experience with her to this important position."
Ms. Yaskal, a resident of Portage, is currently an assistant corporation counsel for Sauk County. As an assistant corporation counsel, Ms. Yaskal handles mental health commitments and child in need of protective services petitions. In addition, she serves on Sauk County’s Juvenile Justice Committee, Child Death Review Team, and the Drug Endangered Children Team. Prior to that, Ms. Yaskal served as an assistant district attorney for Columbia County for 10 years. Ms. Yaskal prosecuted hundreds of cases, which ranged from speeding violations to sexual assault and homicide.
“Brenda Yaskal is a seasoned criminal prosecutor who will bring more than a decade of experience with her to this important position,” said Gov. Evers. “She has a smart approach to criminal justice and a strong relationship with local law enforcement. I am confident Ms. Yaskal will serve the people of Columbia County well.”
Gov. Evers’ appointment of Ms. Yaskal fills a vacancy created by the resignation of the previous district attorney, who resigned on April 9, 2019. Ms. Yaskal will fill the remainder of the unexpired term that ends in January 2021.
Office of the Governor
Recent Press Releases by Gov. Tony Evers
Gov. Evers Announces Search for Next Secretary and CEO of Wisconsin Economic Development CorporationJul 18th, 2019 by Gov. Tony Evers
Gov. Evers is running a transparent process to find the best candidate to lead the Wisconsin Economic Development Corporation and is encouraging qualified applicants to apply online.
"We're working to ensure deaf and hard of hearing folks across our state have access to reliable and experienced interpreters no matter the situation or circumstance."
Gov. Evers Announces Nexus Pharmaceuticals to Build Sterile Injectable Manufacturing Facility in Pleasant PrairieJul 10th, 2019 by Gov. Tony Evers
The Pleasant Prairie manufacturing facility will support the production and supply of drugs in an array of therapeutic areas, including anesthesia, oncology, cardiovascular and neurology.